thenewsfacts.com
  • Home
  • Latest News
  • Trending News
  • Entertainment
  • Technology
  • Sports
  • Business
  • Health
thenewsfacts.comthenewsfacts.com
Font ResizerAa
Search
  • Home
  • Latest News
  • Trending News
  • Entertainment
  • Technology
  • Sports
  • Business
  • Health
Follow US
© thenewsfacts : All Rights Reserved.

Home » Tata Institute Tablet Against Cancer Recurrence for ₹100 Holds Great Promise

Latest News

Tata Institute Tablet Against Cancer Recurrence for ₹100 Holds Great Promise

TheNewsFacts
Last updated: March 1, 2024 5:35 pm
TheNewsFacts
Share
TIFR Cancer Tablet for Rs. 100
Tata Institute Tablet Against Cancer Recurrence for ₹100 Holds Great Promise
SHARE

March 1: Tata Institute of Fundamental Research (TIFR) has unveiled a novel medicine – a pro-oxidant tablet in the fight against cancer. The tablet also diminishes the overall side effects of cancer treatment by approximately 50%.

The institute’s pioneering pro-oxidant Tablet Against Cancer Recurrence, named R+Cu, combines resveratrol and copper. This innovative tablet aims to aid cancer prevention by inhibiting the recurrence of this deadly disease.

This tablet is the outcome of over a decade of dedicated research at the Tata Memorial Centre, scientists have successfully formulated this cutting-edge tablet. Priced at approximately Rs100 ($1.2), the R+Cu tablet is set to make a significant impact in the field of oncology.

According to reports from NDTV, this new advancement holds immense promise in the battle against cancer. The pro-oxidant tablet has shown a 30% effectiveness in preventing cancer.

The tablet against cancer recurrence claims to diminish the overall side effects of cancer treatment by approximately 50%

The research conducted at the TIFR has shed light on the role of cell-free chromatin particles (cfChPs) in triggering cancer development within healthy cells. These remnants of cancer cells have been identified as key instigators of tumor formation, emphasizing the critical need for targeted interventions. Upon ingestion, the R+Cu tablet initiates the production of oxygen radicals within the stomach.

These radicals swiftly enter the bloodstream, where they specifically target and eliminate cfChPs. By disrupting this process, the tablet effectively impedes metastasis—the dangerous spread of cancer cells to other parts of the body.

TAGGED: Cancer Prevention, Cancer Recurrence, Tablet against cancer recurrence prevention, TIFT Cancer Tablet
Share This Article
Twitter Email Copy Link Print
Previous Article Mineral Blocks Auction in India Announced India Auctions 18 Critical Mineral Blocks for Green Energy Goals worth ₹30 Lakh Crore
Next Article Rameshwaram Cafe Bengaluru Authorities Hunt for Bus-Bound Rameshwaram Cafe Bomber

Your Trusted Source for Accurate and Timely Updates!

We're committed to providing accurate and unbiased news as it unfolds, earning the trust of a large audience. Stay informed with our news updates on the latest events and trends, keeping you ahead of the curve.
FacebookLike
TwitterFollow
InstagramFollow

Popular Posts

Jeremy Renner: Overcomes Adversity with Love and Strength

Actor Jeremy Renner, known for his iconic roles in the Avengers franchise and The Bourne…

By TheNewsFacts

India Approves COVAXIN for Children 6 to 12 Years Age

Hyderabad: India has approved COVAXIN for children 6 to 12 years of age today. Bharat…

By TheNewsFacts

35 Crore people vaccinated for COVID19 in India

COVID-19 cases update - India reported 34,703 fresh Covid cases in the last 24 hours,…

By TheNewsFacts

You Might Also Like

Bhool Chuk Maaf Box Office Report
Latest News

Bhool Chuk Maaf Crosses ₹54 Cr Globally in 7 Days

By NewsFacts Bureau
Bharat Biotech HILLCHOL
Latest News

Bharat Biotech’s Oral Cholera Vaccine HILLCHOL Demonstrates Success in Phase III Clinical Studies

By TheNewsFacts
Biovet Lumpy Skin Disease Vaccine Launched
Latest News

BIOLUMPIVAXIN: New Vaccine Now Available to Protect Livestock from LSD

By NewsFacts Bureau
Google AI First Accelerator 2025 India
Latest News

Google Opens 2025 India AI First Accelerator: $17B Opportunity for Startups

By NewsFacts Bureau
thenewsfacts thenewsfacts

About US


TheNewsFacts: Brings you the interesting facts, news facts and updates from India an the world across politics, tech, entertainment, business, tending, and more. We deliver what you love to read.
Top Categories
  • Latest News
  • Trending News
  • Paris Olympics 2024
  • Sports
  • Entertainment
  • Business
  • Technology
Usefull Links
  • About The News Facts
  • Latest News
  • Privacy Policy
  • Editorial Policy
  • Disclaimer
  • Contact Us
Follow us
Facebook Twitter Instagram

© thenewsfacts. All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?